Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Aug 22, 2022)
Date Submitted: Aug 16, 2022
Open Peer Review Period: Aug 16, 2022 - Aug 22, 2022
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Convolutional Neural Networks to Classify Alzheimer’s Disease Severity Based on SPECT Images: A Comparative Study
ABSTRACT
Background:
Image-based recognition has become a long-term topic in the field of artificial intelligence, and neuroimaging has gradually become a beneficial way to understand the course of Alzheimer’s disease (AD).
Objective:
The goal of this study is to compare the detection performance of convolutional neural networks (CNNs) on medical images to establish a classification model for epidemiological research. However, medical image analysis lacks large labeled training datasets, and thus many transfer learning-based methods have been proposed to solve few labels in the medical field.
Methods:
Owing to the scarcity of image data from single-photon emission computed tomography (SPECT), this study uses transfer learning to compare the performance of diagnostic methods based on five different CNNs (two lightweight and three deeper-weight CNN models) to determine the most suitable model. Brain scan image data were collected from 36 male and 63 female subjects. This study used 4711 images as the input data for the model.
Results:
The Cognitive Abilities Screening Instrument and Mini Mental State Exam scores of subjects with Clinical Dementia Rating (CDR) of 2 were significantly lower than those of subjects with CDR of 1 and 0.5. These results indicate that the ResNet model (the deeper-weight CNN model) exhibits the highest accuracy (70.79%) and can hence be used to improve the classification of mild cognitive impairment (MCI), mild AD, and moderate AD (CDRs of 0.5, 1, and 2, respectively).
Conclusions:
This study successfully analyzes the classification performance of different CNN architectures for medical images and also proves the effectiveness of transfer learning in identifying the MCI, mild AD, and moderate AD scoring based on SPECT images.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.